期刊文献+

RP-HPLC法测定人血清中舒芬太尼的浓度 被引量:3

Determination of Sufentanil Concentration in Human Serum by RP-HPLC
原文传递
导出
摘要 目的:建立测定人血清中舒芬太尼浓度的简便方法。方法:血清中舒芬太尼用乙酸乙酯-石油醚(4:1)单步提取后采用反相高效液相色谱法进行测定,其中色谱柱为Symmetry C18,流动相为乙腈-0.02mol.L-1醋酸铵-盐酸(pH4.3)(45:55),检测波长为230nm,柱温为室温,内标为艾司唑仑。结果:舒芬太尼血药浓度在0.025~4.000μg.mL-1范围内线性关系良好(r=0.9999);日内、日间RSD分别为3.49%~4.51%、4.67%~5.99%,平均回收率为101.92%~107.04%。结论:本方法提取步骤少,方法简单、快速、专一性强、准确,适合人血清中舒芬太尼的浓度监测。 OBJECTIVE: To establish the method for the determination of sufentanil concentration in human serum. METH- ODS: Sufentanil was extracted from serum by ethyl ethanoate-petroleum ether(4:1) and determined by RP-HPLC. The determination was performed on Symmetry C18 column with mobile phase consisted of acetonitrile-0.02 mol. L ^-1 NH4Ac-HCL (pH4.3)(45: 55). The detection wavelength was set at 230 nm and the column temperature was room temperature. Estazolam was used as internal standard. RESULTS: The linear range of sufentanil was 0.025-4.000μg·mL^-1(r=0.999 9) with intra-day and inter-day RSDs of 3.49% -4.51% and 4.67% -5.99%. Average recoveries were 101.92% -107.04%. CONCLUSION: The method is simple, rapid, accurate and specific with few steps. It is suitable for drug concentration monitoring of sufentanil in human serum.
出处 《中国药房》 CAS CSCD 2012年第6期528-529,共2页 China Pharmacy
关键词 反相高效液相色谱法 舒芬太尼 血药浓度 药动学 RP-HPLC Sufentanil Serum concentration Pharmacokinetics
  • 相关文献

参考文献3

二级参考文献16

  • 1曹兴华,郑宏,王江,王蕊,刘进.气相色谱-质谱法测定丙泊酚血浆和全血浓度的比较[J].临床麻醉学杂志,2004,20(7):405-407. 被引量:10
  • 2舒芬太尼多中心研讨会纪要[J].临床麻醉学杂志,2004,20(11):668-668. 被引量:48
  • 3Gerlach K,Uhlig T,Huppe M,et al.Remifentanil-clonidinepropofol versus sufentanil-propofol anesthesia for coronary artery bypass surgery.J Cardiothoracic Vasc Anesth,2002,16:703-708.
  • 4Estebe JP,Le Conr P,Levron JC,et al.Pilot study on the effect of tourniquet use on sufentanil pharmacokinetics.Clin Anesth,2002,14,578-583.
  • 5Niemegeers DJE, Schellekens KHL, van Bever WFE, et al. Sufentanil, a very potent and extremely safe intravenous morphine - like compound in mice, rats and dogs. Arzneim Forsch, 1976,26 : 1551
  • 6Leysen JE, Gommeren W, Niemegeers CJE. [^ 3 H ] Sufentanil, a supe- rior ligand for μ - opoate receptors : binding properties and regional distribution in rat brain and spinal cord. Eur J Pharmacol, 1983, 87:209
  • 7Goldstein A, Naidu A. Multiple opoid receptors: ligand selectivity profiles and binding site signatures. Mol Pharmacol, 1989,36:265
  • 8XUEFu-shan(薛富善) ZHAOJun(赵俊).Pharmacological study of sulfentanil(舒芬太尼的药理学研究)[J].实用麻醉学杂志,1991,3:41-41.
  • 9Murkin JM. Sulfentanll anesthesia for major surgery :the multicentre Canadian clinical trial. Can J naesth,1989,36(3 pt Ⅰ) :343
  • 10Shafer SL,Varvel JR. Pharmacokineties, pharmacodynamics and rational opoid selection. Anesthesiology, 1991,74:53

共引文献56

同被引文献26

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部